Loading…
Scienture Holdings, Inc. is projected to rise to $0.4047 by 2027, a +5% move from its current price of $0.387. SCNX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.3748 | $0.3873 | $0.4002 | +0.08% |
| Aug 6 | $0.3701 | $0.3876 | $0.406 | +0.16% |
| Aug 7 | $0.3665 | $0.3879 | $0.4106 | +0.24% |
| Aug 8 | $0.3636 | $0.3882 | $0.4145 | +0.32% |
| Aug 9 | $0.3611 | $0.3886 | $0.4181 | +0.40% |
| Aug 10 | $0.3589 | $0.3889 | $0.4213 | +0.48% |
| Aug 11 | $0.3569 | $0.3892 | $0.4244 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3569 | $0.3892 | $0.4244 | +0.56% |
| Week 2 | $0.3463 | $0.3914 | $0.4424 | +1.13% |
| Week 3 | $0.3388 | $0.3936 | $0.4573 | +1.70% |
| Week 4 | $0.3329 | $0.3958 | $0.4707 | +2.28% |
| Week 5 | $0.328 | $0.3981 | $0.4831 | +2.86% |
| Week 6 | $0.3238 | $0.4003 | $0.4949 | +3.44% |
| Week 7 | $0.3201 | $0.4026 | $0.5063 | +4.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Scienture Holdings, Inc. operates as a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen.
It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.
SCNX is Scienture Holdings, Inc. stock. The current price is $0.3693 with a market cap of $15M and a rank of 4745. The stock sits in the healthcare sector as a pharmaceutical company with a small-cap footprint.
A major floor 37.7% below — a decisive break under it would weaken the trend.
The nearest floor, 14.5% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 19.1% above — clearing it would confirm fresh momentum.
Key SCNX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SCNX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3742 | Buy | $0.3783 | Buy |
| MA 10 | $0.3836 | Buy | $0.3798 | Buy |
| MA 20 | $0.3771 | Buy | $0.3788 | Buy |
| MA 50 | $0.3773 | Buy | $0.3806 | Buy |
| MA 100 | $0.3877 | Sell | $0.4147 | Sell |
| MA 200 | $0.4873 | Sell | $0.692 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.00 | Neutral |
| Stoch RSI (14) | 27.78 | Neutral |
| CCI (20) | 12.21 | Neutral |
| Williams %R (14) | -70.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -6.62 | Sell |
| Bollinger %B (20,2) | 0.54 | Neutral |
| Stochastic %K (14) | 30.00 | Neutral |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 44.04 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 0.37 | Buy |
| ADX (14) | 11.97 | Neutral |
| ATR (14) | 0.01 | Info |
The stock’s near-term technical picture shows a neutral stance, with RSI14 at 50. The price trades around the 50-day moving average of $0.3806 and remains below the 200-day moving average of $0.4991.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.241 | $0.387 | $0.5426 | 0% | Neutral | |
| $0.317 | $0.4047 | $0.5495 | +5% | Neutral | |
| $0.2923 | $0.3863 | $0.5482 | 0% | Neutral | |
| $0.2762 | $0.3757 | $0.5516 | -3% | Neutral | |
| $0.2793 | $0.3897 | $0.5887 | +1% | Neutral | |
| $0.3059 | $0.4369 | $0.6764 | +13% | Neutral | |
| $0.3296 | $0.481 | $0.7611 | +24% | Bullish | |
| $0.3573 | $0.5322 | $0.8592 | +38% | Bullish | |
| $0.3469 | $0.527 | $0.8663 | +36% | Bullish | |
| $0.3183 | $0.4927 | $0.8237 | +27% | Bullish | |
| $0.3997 | $0.6741 | $1.21 | +74% | Bullish | |
| $0.5496 | $1.08 | $2.14 | +179% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.241 | $0.387 | $0.4711 | +0.00% |
| September 2026 | $0.3454 | $0.4107 | $0.5037 | +6.13% |
| October 2026 | $0.3473 | $0.4165 | $0.5174 | +1.40% |
| November 2026 | $0.3427 | $0.4137 | $0.5192 | -0.66% |
| December 2026 | $0.3526 | $0.4284 | $0.5426 | +3.54% |
Click any year to see its month-by-month SCNX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SCNX could reach as high as $0.5426, with a base case around $0.387 and support toward $0.241 — roughly 0% from $0.387. A consolidation phase looks the most probable path here.
Expect SCNX to range from $0.317 to $0.5495 through 2027. The $0.4047 average target implies a +5% move from current prices. That is up +5% on the projected 2026 average. Price action looks broadly range-bound.
The SCNX price prediction for 2028 points to an average of $0.3863 (low $0.2923, high $0.5482) — a potential decline of 0% on today's $0.387. A consolidation phase looks the most probable path here.
In 2029, SCNX is projected to trade between $0.2762 and $0.5516, averaging $0.3757 — a potential decline of -3% from today's $0.387. That is -3% versus the projected 2028 average. Price action looks broadly range-bound.
Scienture Holdings, Inc.'s 2030 outlook centres on $0.3897, within a $0.2793 to $0.5887 range. That is up +4% on the projected 2029 average. That marks a +1% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, SCNX could reach as high as $0.6764, with a base case around $0.4369 and support toward $0.3059 — roughly +13% from $0.387. Price action looks broadly range-bound.
Expect SCNX to range from $0.3296 to $0.7611 through 2032. The $0.481 average target implies a +24% move from current prices. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SCNX price prediction for 2033 points to an average of $0.5322 (low $0.3573, high $0.8592) — a potential gain of +38% on today's $0.387. Momentum favours further upside here.
In 2034, SCNX is projected to trade between $0.3469 and $0.8663, averaging $0.527 — a potential gain of +36% from today's $0.387. That is -1% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Scienture Holdings, Inc.'s 2035 outlook centres on $0.4927, within a $0.3183 to $0.8237 range. That is -7% versus the projected 2034 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2040, SCNX could reach as high as $1.21, with a base case around $0.6741 and support toward $0.3997 — roughly +74% from $0.387. Buyers look set to stay in control over this stretch.
Expect SCNX to range from $0.5496 to $2.14 through 2050. The $1.08 average target implies a +179% move from current prices. That is up +60% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SCNX today (≈ 2,583.979328 SCNX) could be worth
$2,788.12
+$1,788.12 (+179%) by 2050 · US Dollar
Based on the average projected SCNX price of $1.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SCNXwould be worth at today's price.
$1,000 invested in SCNX on Jul 31, 2025 (≈ 515.463902 SCNX) would be worth
$199.48
-$800.52 (-80.1%) today · 0.20× · US Dollar
Based on a SCNX entry price of $1.94 vs. today's $0.387.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.369 | $1,048.78 | +4.9% |
| 1 month ago | $0.356 | $1,087.08 | +8.7% |
| 3 months ago | $0.401 | $965.09 | -3.5% |
| 6 months ago | $0.453 | $854.3 | -14.6% |
| 1 year ago | $1.94 | $199.48 | -80.1% |
| All time (5.0y) ago | $77.7 | $4.98 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SCNX forecast.
Our base-case forecast reaches $0.77 around 2050.
Implied market cap at $0.77: $31.29M
Looking ahead, the multi-year forecast shows a path of gradual change with notable moves in later years. In 2026 the average is $0.3693 with a min of $0.241 and a max of $0.5341 (ROI 0). In 2027 the average rises to $0.3807 (min $0.2953, max $0.5236; ROI 3.1%).
In 2028 the average is $0.3644 (min $0.2723, max $0.5251; ROI -1.3%). In 2029 the average is $0.3637 (min $0.2633, max $0.5431; ROI -1.5%). In 2030 the average is $0.3645 (min $0.2567, max $0.561; ROI -1.3%).
Beginning in 2031 the forecast turns more positive, with 2031 avg $0.416 (min $0.2856, max $0.657; ROI 12.6%), 2032 avg $0.4688 (min $0.3143, max $0.7578; ROI 27%), 2033 avg $0.5077 (min $0.3328, max $0.838; ROI 37.5%), 2034 avg $0.5053 (min $0.3241, max $0.8501; ROI 36.8%), and 2035 avg $0.4719 (min $0.2965, max $0.8081; ROI 27.8%). In 2040 the average rises to $0.6459 (min $0.3689, max $1.19; ROI 74.9%), and by 2050 the average is $1.05 (min $0.503, max $2.14; ROI 183.1%).
Tap a question to reveal the answer.
Avg $0.3645; min $0.2567; max $0.561; ROI -1.3%; sentiment NEUTRAL.
Forecasts show a path toward higher prices in later years with 2031 ROI 12.6%, 2032 ROI 27%, 2033 ROI 37.5%, 2040 ROI 74.9%, and 2050 ROI 183.1%; however, 2026-2030 include flat or negative ROIs, and these figures are estimates, not guarantees.
Yes. The 2050 max forecast is $2.14 with ROI 183.1% and an avg of $1.05.
Min $0.241, avg $0.3693, max $0.5341; sentiment NEUTRAL.
Current price is $0.3693 and market cap is $15M.
Scienture Holdings, Inc. Community Discussion
0Share your Scienture Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.